企業プロフィール
SpringWorks Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- SWTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for SWTX.
企業概要
事業概要
SpringWorks Therapeutics is a rare-disease and oncology biotech focused on targeted treatments for genetically defined conditions. Its story blends commercial execution with a highly focused pipeline.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, SpringWorks sits in specialty biopharma.
ビジネスモデルの特徴
The company combines product revenue with pipeline development, so investors watch launch progress, label expansion, and regulatory milestones.
バイオ業界での位置付け
SpringWorks is a focused specialty-biotech name whose stock can move sharply on data and commercial milestones.
今後のカタリスト
- SpringWorks's catalysts are nirogacestat in desmoid tumors and mirdametinib in NF1-PN, both of which can move the stock if commercial and late-stage execution stay clean. The company is still building its rare-disease franchise.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。